These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35336926)

  • 1. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity.
    Obermann W; Friedrich A; Madhugiri R; Klemm P; Mengel JP; Hain T; Pleschka S; Wendel HG; Hartmann RK; Schiffmann S; Ziebuhr J; Müller C; Grünweller A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
    Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
    Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics.
    Taroncher-Oldenburg G; Müller C; Obermann W; Ziebuhr J; Hartmann RK; Grünweller A
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33807988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent anti-coronaviral activity of pateamines and new insights into their mode of action.
    Magari F; Messner H; Salisch F; Schmelzle SM; van Zandbergen G; Fürstner A; Ziebuhr J; Heine A; Müller-Ruttloff C; Grünweller A
    Heliyon; 2024 Jul; 10(13):e33409. PubMed ID: 39035482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System.
    Schiffmann S; Henke M; Seifert M; Ulshöfer T; Roser LA; Magari F; Wendel HG; Grünweller A; Parnham MJ
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis.
    Keiser PT; Zhang W; Ricca M; Wacquiez A; Grimins A; Cencic R; Patten JJ; Shah P; Padilha E; Connor JH; Pelletier J; Lyons SM; Saeed M; Brown LE; Porco JA; Davey RA
    Antiviral Res; 2024 Oct; 230():105976. PubMed ID: 39117283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses.
    Müller C; Schulte FW; Lange-Grünweller K; Obermann W; Madhugiri R; Pleschka S; Ziebuhr J; Hartmann RK; Grünweller A
    Antiviral Res; 2018 Feb; 150():123-129. PubMed ID: 29258862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
    Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
    Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
    Chu J; Zhang W; Cencic R; Devine WG; Beglov D; Henkel T; Brown LE; Vajda S; Porco JA; Pelletier J
    Cell Chem Biol; 2019 Nov; 26(11):1586-1593.e3. PubMed ID: 31519508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural compound silvestrol is a potent inhibitor of Ebola virus replication.
    Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A
    Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad anti-pathogen potential of DEAD box RNA helicase eIF4A-targeting rocaglates.
    Obermann W; Azri MFD; Konopka L; Schmidt N; Magari F; Sherman J; Silva LMR; Hermosilla C; Ludewig AH; Houhou H; Haeberlein S; Luo MY; Häcker I; Schetelig MF; Grevelding CG; Schroeder FC; Lau GSK; Taubert A; Rodriguez A; Heine A; Yeo TC; Grünweller A; Taroncher-Oldenburg G
    Sci Rep; 2023 Jun; 13(1):9297. PubMed ID: 37291191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A parasitic fungus employs mutated eIF4A to survive on rocaglate-synthesizing
    Chen M; Kumakura N; Saito H; Muller R; Nishimoto M; Mito M; Gan P; Ingolia NT; Shirasu K; Ito T; Shichino Y; Iwasaki S
    Elife; 2023 Feb; 12():. PubMed ID: 36852480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the targeting spectrum of rocaglates among eIF4A homologs.
    Naineni SK; Cencic R; Robert F; Brown LE; Haque M; Scott-Talib J; Sénéchal P; Schmeing TM; Porco JA; Pelletier J
    RNA; 2023 Jun; 29(6):826-835. PubMed ID: 36882295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Zika Virus Replication by Silvestrol.
    Elgner F; Sabino C; Basic M; Ploen D; Grünweller A; Hildt E
    Viruses; 2018 Mar; 10(4):. PubMed ID: 29584632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A forward genetic screen identifies modifiers of rocaglate responsiveness.
    Shen L; Pugsley L; Cencic R; Wang H; Robert F; Naineni SK; Sahni A; Morin G; Zhang W; Nijnik A; Porco JA; Langlais D; Huang S; Pelletier J
    Sci Rep; 2021 Sep; 11(1):18516. PubMed ID: 34531456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol.
    Glitscher M; Himmelsbach K; Woytinek K; Johne R; Reuter A; Spiric J; Schwaben L; Grünweller A; Hildt E
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29865243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
    Iwasaki S; Floor SN; Ingolia NT
    Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F.
    Chu J; Zhang W; Cencic R; O'Connor PBF; Robert F; Devine WG; Selznick A; Henkel T; Merrick WC; Brown LE; Baranov PV; Porco JA; Pelletier J
    Cell Rep; 2020 Feb; 30(8):2481-2488.e5. PubMed ID: 32101697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-RNA interactions mediated by silvestrol-insight into a unique molecular clamp.
    Naineni SK; Bhatt G; Jiramongkolsiri E; Robert F; Cencic R; Huang S; Nagar B; Pelletier J
    Nucleic Acids Res; 2024 Nov; 52(20):12701-12711. PubMed ID: 39351865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halogenated Rocaglate Derivatives: Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses.
    Victoria C; Schulz G; Klöhn M; Weber S; Holicki CM; Brüggemann Y; Becker M; Gerold G; Eiden M; Groschup MH; Steinmann E; Kirschning A
    J Med Chem; 2024 Jan; 67(1):289-321. PubMed ID: 38127656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.